News
Telemedicine offers solution for late cancellations and no-show appointments
Converting these missed appointments to telemedicine resulted in more than 250 additional hours of patient care as well as moderate revenue loss...
News
Split-dose methotrexate speeds RA response over single dose
Compared with a single dose, more patients in the split-dose group had improved disease activity at 16 weeks, and fewer needed additional DMARDs,...
News
First referral guide issued for axial spondyloarthritis
The draft recommendations are a “good first step,” but more awareness around axial spondyloarthritis in the nonrheumatology community is also...
News
TNF blockers not associated with poorer pregnancy outcomes
Patients with rheumatic disease who continued TNF blockers during their pregnancy did not have an increased risk of worse fetal and maternal...
News
Pregnancy in rheumatic disease quadruples risk of cardiovascular events
Pregnant patients with lupus and concomitant APS had an 18-fold higher risk for a cardiovascular event during and up to 6 weeks postpartum than...
News
FDA OKs first ustekinumab biosimilar
The drug has also been granted an interchangeability designation and has been approved for six indications.
News
FDA approves abatacept for pediatric patients with psoriatic arthritis
As many as 5% of pediatric patients with juvenile idiopathic arthritis are estimated to have juvenile PsA.
News
RA precision medicine using synovial biopsy ‘remains elusive’
Histologic analysis did not sufficiently predict treatment response to certain medications, but gene expression and transcriptome analysis methods...
News
Tech encourages HIV prevention among women
“Mobile technologies, in particular, offer a nimble, customizable, and accessible way to reach this target population and increase awareness of...
News
FDA warns of hidden ingredients in arthritis, pain products
“I don’t know if this was intentional, but it seems suspicious that a product marketed to reduce joint pain and inflammation contains prescription...
News
Researchers link two genes to Raynaud’s disease
The discovery will hopefully lead to new therapeutic avenues for the condition, experts say.
News
Tool in development aims to steer telehealth visit appropriateness in rheumatology
The model, using patient characteristics as well as provider preferences, suggests when certain visits can be carried out via telehealth.
News
Intravenous formulation of secukinumab gets FDA approval
This new route of administration is expected to become available during the fourth quarter of 2023.
News
More evidence shows COVID-19’s link to risk for autoimmune disease
Patients with more severe COVID-19 that required hospitalization in the ICU were more likely to develop vasculitis, alopecia totalis, and several...
News
FDA approves ninth Humira biosimilar, with interchangeability
The drug, adalimumab-afzb (Abrilada), is the second adalimumab biosimilar approved with interchangeability status. It will be available in late...